TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)

Ayalew Tefferi, Farah Fleti, Onyee Chan, Najla H. Al Ali, Aref Al-Kali, Kebede H. Begna, James M. Foran, Talha Badar, Nandita Khera, Mithun Shah, Devendra Hiwase, Eric Padron, David A. Sallman, Animesh Pardanani, Daniel A. Arber, Attilio Orazi, Kaaren K. Reichard, Rong He, Rhett P. Ketterling, Naseema GangatRami Komrokji

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)'. Together they form a unique fingerprint.

Medicine & Life Sciences